PTH Holdings — Invesco Dorsey Wright Healthcare Momentum ETF
All 61 reported holdings of Invesco Dorsey Wright Healthcare Momentum ETF (PTH) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Invesco Private Prime Fund | 22.92% | $27.71M |
| Invesco Private Government Fund | 8.83% | $10.68M |
| Praxis Precision Medicines, Inc. | 5.08% | $6.14M |
| Roivant Sciences Ltd. | 4.65% | $5.62M |
| United Therapeutics Corp. | 3.43% | $4.15M |
| Tenet Healthcare Corp. | 3.04% | $3.67M |
| Terns Pharmaceuticals, Inc. | 2.86% | $3.46M |
| Tango Therapeutics Inc. | 2.85% | $3.45M |
| HCA Healthcare, Inc. | 2.78% | $3.36M |
| Axsome Therapeutics, Inc. | 2.64% | $3.20M |
| Nektar Therapeutics | 2.57% | $3.11M |
| Celcuity Inc. | 2.53% | $3.06M |
| Ionis Pharmaceuticals, Inc. | 2.37% | $2.87M |
| Capricor Therapeutics, Inc. | 2.26% | $2.73M |
| Cencora, Inc. | 2.25% | $2.72M |
| Alumis Inc. | 2.12% | $2.56M |
| Gilead Sciences, Inc. | 1.99% | $2.40M |
| Kodiak Sciences Inc. | 1.99% | $2.40M |
| BrightSpring Health Services, Inc. | 1.98% | $2.39M |
| Jazz Pharmaceuticals PLC | 1.92% | $2.32M |
| Moderna, Inc. | 1.90% | $2.30M |
| Protagonist Therapeutics, Inc. | 1.90% | $2.29M |
| Viatris Inc. | 1.88% | $2.27M |
| Dianthus Therapeutics, Inc. | 1.80% | $2.17M |
| AnaptysBio, Inc. | 1.78% | $2.15M |
| Ensign Group, Inc. (The) | 1.73% | $2.10M |
| Incyte Corp. | 1.71% | $2.07M |
| Erasca, Inc. | 1.71% | $2.07M |
| Ligand Pharmaceuticals Inc. | 1.62% | $1.95M |
| Oruka Therapeutics, Inc. | 1.60% | $1.94M |
| CG Oncology, Inc. | 1.55% | $1.88M |
| Tyra Biosciences, Inc. | 1.54% | $1.86M |
| SELLAS Life Sciences Group, Inc. | 1.50% | $1.82M |
| Spyre Therapeutics, Inc. | 1.49% | $1.80M |
| Kymera Therapeutics, Inc. | 1.46% | $1.77M |
| Twist Bioscience Corp. | 1.45% | $1.76M |
| Liquidia Corp. | 1.42% | $1.71M |
| Brookdale Senior Living Inc. | 1.41% | $1.71M |
| Axogen, Inc. | 1.37% | $1.65M |
| Exelixis, Inc. | 1.33% | $1.61M |
| Edgewise Therapeutics, Inc. | 1.31% | $1.59M |
| Trevi Therapeutics, Inc. | 1.30% | $1.57M |
| Cytokinetics, Inc. | 1.19% | $1.44M |
| Elanco Animal Health Inc. | 1.16% | $1.41M |
| Relay Therapeutics, Inc. | 1.13% | $1.37M |
| Dyne Therapeutics, Inc. | 1.12% | $1.36M |
| Vaxcyte, Inc. | 1.12% | $1.35M |
| Krystal Biotech, Inc. | 1.10% | $1.33M |
| Enliven Therapeutics, Inc. | 1.07% | $1.29M |
| Arcus Biosciences, Inc. | 0.94% | $1.14M |
| Annexon, Inc. | 0.92% | $1.11M |
| Stoke Therapeutics, Inc. | 0.91% | $1.10M |
| Phibro Animal Health Corp. | 0.90% | $1.09M |
| MoonLake Immunotherapeutics | 0.79% | $951.53K |
| BioAge Labs, Inc. | 0.77% | $932.60K |
| Syndax Pharmaceuticals, Inc. | 0.73% | $878.91K |
| Perspective Therapeutics Inc. | 0.67% | $809.14K |
| Zenas Biopharma, Inc. | 0.63% | $766.64K |
| Viridian Therapeutics, Inc. | 0.58% | $702.29K |
| Maze Therapeutics, Inc. | 0.51% | $613.09K |
| Invesco Government & Agency Portfolio | 0.27% | $322.24K |